Mouse model of pulmonary cavitary tuberculosis and expression of matrix metalloproteinase-9

DMM Disease Models and Mechanisms

Volumn 9, Issue 7, 2016, Pages 779-788

  Ordonez, Alvaro A ^a   Tasneen, Rokeya ^a   Pokkali, Supriya ^a   Xu, Ziyue ^b   Converse, Paul J ^a   Klunk, Mariah H ^a   Mollura, Daniel J ^b   Nuermberger, Eric L ^a   Jain, Sanjay K ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cavity; Computed tomography; Matrix metalloproteinases; Mice; Tuberculosis

Indexed keywords

GELATINASE B; ISONIAZID; MATRILYSIN; PYRAZINAMIDE; RIFAMPICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C3HEB/FE MOUSE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; FLUORESCENCE IMAGING; INFLAMMATORY CELL; LUNG CAVITATION; LUNG PARENCHYMA; LUNG TUBERCULOSIS; MOUSE; MOUSE MODEL; MOUSE STRAIN; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME; ANIMAL; DIAGNOSTIC IMAGING; DISEASE MODEL; ENZYMOLOGY; INFLAMMATION; LUNG; MACROPHAGE; METABOLISM; PATHOLOGY; X-RAY COMPUTED TOMOGRAPHY;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION; LUNG; MACROPHAGES; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; MICE; TOMOGRAPHY, X-RAY COMPUTED; TUBERCULOSIS, PULMONARY;

EID: 84977489233     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.025643     Document Type: Article

References (66)

1. Abhimanyu, Jha, P., Jain, A., Arora, K. And Bose, M. (2011). Genetic association study suggests a role for SP110 variants in lymph node tuberculosis but not pulmonary tuberculosis in north Indians. Hum. Immunol. 72, 576-580.
2. Benator, D., Bhattacharya, M., Bozeman, L., Burman, W., Cantazaro, A., Chaisson, R., Gordin, F., Horsburgh, C. R., Horton, J., Khan, A. et al., Tuberculosis Trials Consortium (2002). Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. Lancet 360, 528-534.
3. Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J. et al. (2010). An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973-977.
4. Blumberg, H. M., Burman, W. J., Chaisson, R. E., Daley, C. L., Etkind, S. C., Friedman, L. N., Fujiwara, P., Grzemska, M., Hopewell, P. C., Iseman, M. D. et al., American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society (2003). American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am. J. Respir. Crit. Care Med. 167, 603-662.
5. Burke, B., Giannoudis, A., Corke, K. P., Gill, D., Wells, M., Ziegler-Heitbrock, L. And Lewis, C. E. (2003). Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. Am. J. Pathol. 163, 1233-1243.
6. Canetti, G. (1955). The Tubercle Bacillus in the Pulmonary Lesion of Man. New York, NY: Springer Publishing Co., Inc.
7. Canetti, G. (1965). Present aspects of bacterial resistance in tuberculosis. Am. Rev. Respir. Dis. 92, 687-703.
8. Capuano, S. V., III, Croix, D. A., Pawar, S., Zinovik, A., Myers, A., Lin, P. L., Bissel, S., Fuhrman, C., Klein, E. And Flynn, J. L. (2003). Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect. Immun. 71, 5831-5844.
9. Chen, R. Y., Dodd, L. E., Lee, M., Paripati, P., Hammoud, D. A., Mountz, J. M., Jeon, D., Zia, N., Zahiri, H., Coleman, M. T. et al. (2014). PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis. Sci. Transl. Med. 6, 265ra166.
10. Converse, P. J., Dannenberg, A. M., Jr., Estep, J. E., Sugisaki, K., Abe, Y., Schofield, B. H. And Pitt, M. L. (1996). Cavitary tuberculosis produced in rabbits by aerosolized virulent tubercle bacilli. Infect. Immun. 64, 4776-4787.
11. Davis, S. L., Nuermberger, E. L., Um, P. K., Vidal, C., Jedynak, B., Pomper, M. G., Bishai, W. R. And Jain, S. K. (2009). Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment. Antimicrob. Agents Chemother. 53, 4879-4884.
12. DeMarco, V. P., Ordonez, A. A., Klunk, M., Prideaux, B., Wang, H., Zhuo, Z., Tonge, P. J., Dannals, R. F., Holt, D. P., Lee, C. K. et al. (2015). Determination of [11C]rifampin pharmacokinetics within Mycobacterium tuberculosis-infected mice by using dynamic positron emission tomography bioimaging. Antimicrob. Agents Chemother. 59, 5768-5774.
13. Dorhoi, A. And Kaufmann, S. H. E. (2016). Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis. Semin. Immunopathol. 38, 153-166.
14. Dorman, S. E., Johnson, J. L., Goldberg, S., Muzanye, G., Padayatchi, N., Bozeman, L., Heilig, C. M., Bernardo, J., Choudhri, S., Grosset, J. H. et al. (2009). Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 180, 273-280.
15. Driver, E. R., Ryan, G. J., Hoff, D. R., Irwin, S. M., Basaraba, R. J., Kramnik, I. And Lenaerts, A. J. (2012). Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 56, 3181-3195.
16. Elkington, P., Shiomi, T., Breen, R., Nuttall, R. K., Ugarte-Gil, C. A., Walker, N. F., Saraiva, L., Pedersen, B., Mauri, F., Lipman, M. et al. (2011). MMP-1 drives immunopathology in human tuberculosis and transgenic mice. J. Clin. Invest. 121, 1827-1833.
17. Eum, S.-Y., Kong, J.-H., Hong, M.-S., Lee, Y.-J., Kim, J.-H., Hwang, S.-H., Cho, S.-N., Via, L. E. And Barry, C. E. III (2010). Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest 137, 122-128.
18. Gendron, R., Grenier, D., Sorsa, T. And Mayrand, D. (1999). Inhibition of the activities of matrix metalloproteinases 2, 8, and 9 by chlorhexidine. Clin. Diagn. Lab. Immunol. 6, 437-439.
19. Gioia, M., Monaco, S., Van Den Steen, P. E., Sbardella, D., Grasso, G., Marini, S., Overall, C. M., Opdenakker, G. And Coletta, M. (2009). The collagen binding domain of gelatinase A modulates degradation of collagen IV by gelatinase B. J. Mol. Biol. 386, 419-434.
20. Greenlee, K. J., Werb, Z. And Kheradmand, F. (2007). Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol. Rev. 87, 69-98.
21. Gu, Z., Cui, J., Brown, S., Fridman, R., Mobashery, S., Strongin, A. Y. And Lipton, S. A. (2005). A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J. Neurosci. 25, 6401-6408.
22. Harper, J., Skerry, C., Davis, S. L., Tasneen, R., Weir, M., Kramnik, I., Bishai, W. R., Pomper, M. G., Nuermberger, E. L. And Jain, S. K. (2012). Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions. J. Infect. Dis. 205, 595-602.
23. He, X., Berland, R., Mekasha, S., Christensen, T. G., Alroy, J., Kramnik, I. And Ingalls, R. R. (2013). The sst1 resistance locus regulates evasion of type I interferon signaling by Chlamydia pneumoniae as a disease tolerance mechanism. PLoS Pathog. 9, e1003569.
24. Hunter, R. L. (2011). Pathology of post primary tuberculosis of the lung: an illustrated critical review. Tuberculosis 91, 497-509.
25. Irwin, S. M., Driver, E., Lyon, E., Schrupp, C., Ryan, G., Gonzalez-Juarrero, M., Basaraba, R. J., Nuermberger, E. L. And Lenaerts, A. J. (2015). Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis. Dis. Model. Mech. 8, 591-602.
26. Irwin, S. M., Prideaux, B., Lyon, E. R., Zimmerman, M. D., Brooks, E. J., Schrupp, C. A., Chen, C., Reichlen, M. J., Asay, B. C., Voskuil, M. I. et al. (2016). Bedaquiline and pyrazinamide treatment responses are affected by pulmonary lesion heterogeneity in Mycobacterium tuberculosis infected C3HeB/FeJ mice. ACS Infect. Dis. 2, 251-267.
27. Jager, N. A., De Vries, B. M. W., Hillebrands, J.-L., Harlaar, N. J., Tio, R. A., Slart, R. H. J. A., Van Dam, G. M., Boersma, H. H., Zeebregts, C. J. And Westra, J. (2016). Distribution of matrix metalloproteinases in human atherosclerotic carotid plaques and their production by smooth muscle cells and macrophage subsets. Mol. Imaging Biol. 18, 238-291.
28. Kaplan, G., Post, F. A., Moreira, A. L., Wainwright, H., Kreiswirth, B. N., Tanverdi, M., Mathema, B., Ramaswamy, S. V., Walther, G., Steyn, L. M. et al. (2003). Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity. Infect. Immun. 71, 7099-7108.
29. Kaushal, D., Mehra, S., Didier, P. And Lackner, A. (2012). The non-human primate model of tuberculosis. J. Med. Primatol. 41, 191-201.
30. Kjellsson, M. C., Via, L. E., Goh, A., Weiner, D., Low, K. M., Kern, S., Pillai, G., Barry, C. E., III and Dartois, V. (2012). Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions. Antimicrob. Agents Chemother. 56, 446-457.
31. Kübler, A., Luna, B., Larsson, C., Ammerman, N. C., Andrade, B. B., Orandle, M., Bock, K. W., Xu, Z., Bagci, U., Molura, D. J. et al. (2015). Mycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation. J. Pathol. 235, 431-444.
32. Kubler, A., Larsson, C., Luna, B., Andrade, B. B., Amaral, E. P., Urbanowski, M., Orandle, M., Bock, K., Ammerman, N. C., Cheung, L. S. et al. (2016). Cathepsin K contributes to cavitation and collagen turnover in pulmonary tuberculosis. J. Infect. Dis. 213, 618-627.
33. Lanoix, J.-P., Lenaerts, A. J. And Nuermberger, E. L. (2015). Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis. Dis. Models Mech. 8, 603-610.
34. Lanoix, J.-P., Betoudji, F. And Nuermberger, E. L. (2016a). Sterilizing activity of pyrazinamide in combination with first-line drugs in a C3HeB/FeJ mouse model of tuberculosis. Antimicrob. Agents Chemother. 60, 1091-1096.
35. Lanoix, J.-P., Ioerger, T., Ormond, A., Kaya, F., Sacchettini, J., Dartois, V. And Nuermberger, E. (2016b). Selective inactivity of pyrazinamide against tuberculosis in C3HeB/FeJ mice is best explained by neutral pH of caseum. Antimicrob. Agents Chemother. 60, 735-743.
36. Lenaerts, A., Barry, C. E., III and Dartois, V. (2015). Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses. Immunol. Rev. 264, 288-307.
37. Lin, P. L., Coleman, T., Carney, J. P. J., Lopresti, B. J., Tomko, J., Fillmore, D., Dartois, V., Scanga, C., Frye, L. J., Janssen, C. et al. (2013). Radiologic responses in cynomolgus macaques for assessing tuberculosis chemotherapy regimens. Antimicrob. Agents Chemother. 57, 4237-4244.
38. Liu, J., Xiong, W., Baca-Regen, L., Nagase, H. And Baxter, B. T. (2003). Mechanism of inhibition of matrix metalloproteinase-2 expression by doxycycline in human aortic smooth muscle cells. J. Vasc. Surg. 38, 1376-1383.
39. Manabe, Y. C., Dannenberg, A. M., Jr., Tyagi, S. K., Hatem, C. L., Yoder, M., Woolwine, S. C., Zook, B. C., Pitt, M. L. M. And Bishai, W. R. (2003). Different strains of Mycobacterium tuberculosis cause various spectrums of disease in the rabbit model of tuberculosis. Infect. Immun. 71, 6004-6011.
40. Marzo, E., Vilaplana, C., Tapia, G., Diaz, J., Garcia, V. And Cardona, P.-J. (2014). Damaging role of neutrophilic infiltration in a mouse model of progressive tuberculosis. Tuberculosis 94, 55-64.
41. Miller, W. T. And Miller, W. T. Jr. (1993). Tuberculosis in the normal host: radiological findings. Semin. Roentgenol. 28, 109-118.
42. Nedeltchev, G. G., Raghunand, T. R., Jassal, M. S., Lun, S., Cheng, Q.-J. And Bishai, W. R. (2009). Extrapulmonary dissemination of Mycobacterium bovis but not Mycobacterium tuberculosis in a bronchoscopic rabbit model of cavitary tuberculosis. Infect. Immun. 77, 598-603.
43. Nuermberger, E. L. (2008). Using animal models to develop new treatments for tuberculosis. Semin. Respir. Crit. Care Med. 29, 542-551.
44. Ong, C. W. M., Elkington, P. T. And Friedland, J. S. (2014). Tuberculosis, pulmonary cavitation, and matrix metalloproteinases. Am. J. Respir. Crit. Care Med. 190, 9-18.
45. Ordonez, A. A., DeMarco, V. P., Klunk, M. H., Pokkali, S. And Jain, S. K. (2015a). Imaging chronic tuberculous lesions using sodium [18F]fluoride positron emission tomography in mice. Mol. Imaging Biol. 17, 609-614.
46. Ordonez, A. A., Pokkali, S., DeMarco, V. P., Klunk, M., Mease, R. C., Foss, C. A., Pomper, M. G. And Jain, S. K. (2015b). Radioiodinated DPA-713 imaging correlates with bactericidal activity of tuberculosis treatments in mice. Antimicrob. Agents Chemother. 59, 642-649.
47. Palaci, M., Dietze, R., Hadad, D. J., Ribeiro, F. K. C., Peres, R. L., Vinhas, S. A., Maciel, E. L. N., Do Valle Dettoni, V., Horter, L., Boom, W. H. et al. (2007). Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis. J. Clin. Microbiol. 45, 4064-4066.
48. Pan, H., Yan, B.-S., Rojas, M., Shebzukhov, Y. V., Zhou, H., Kobzik, L., Higgins, D. E., Daly, M. J., Bloom, B. R. And Kramnik, I. (2005). Ipr1 gene mediates innate immunity to tuberculosis. Nature 434, 767-772.
49. Pichugin, A. V., Yan, B.-S., Sloutsky, A., Kobzik, L. And Kramnik, I. (2009). Dominant role of the sst1 locus in pathogenesis of necrotizing lung granulomas during chronic tuberculosis infection and reactivation in genetically resistant hosts. Am. J. Pathol. 174, 2190-2201.
50. Prideaux, B., Via, L. E., Zimmerman, M. D., Eum, S., Sarathy, J., O'Brien, P., Chen, C., Kaya, F., Weiner, D. M., Chen, P.-Y. et al. (2015). The association between sterilizing activity and drug distribution into tuberculosis lesions. Nat. Med. 21, 1223-1227.
51. Salazar-Austin, N., Ordonez, A. A., Hsu, A. J., Benson, J. E., Mahesh, M., Menachery, E., Razeq, J. H., Salfinger, M., Starke, J. R., Milstone, A. M. et al. (2015). Extensively drug-resistant tuberculosis in a young child after travel to India. Lancet Infect. Dis. 15, 1485-1491.
52. Salgame, P. (2011). MMPs in tuberculosis: granuloma creators and tissue destroyers. J. Clin. Invest. 121, 1686-1688.
53. Sathyamoorthy, T., Sandhu, G., Tezera, L. B., Thomas, R., Singhania, A., Woelk, C. H., Dimitrov, B. D., Agranoff, D., Evans, C. A. W., Friedland, J. S. et al. (2015). Gender-dependent differences in plasma matrix metalloproteinase-8 elevated in pulmonary tuberculosis. PLoS ONE 10, e0117605.
54. Singh, S., Kubler, A., Singh, U. K., Singh, A., Gardiner, H., Prasad, R., Elkington, P. T. And Friedland, J. S. (2014). Antimycobacterial drugs modulate immunopathogenic matrix metalloproteinases in a cellular model of pulmonary tuberculosis. Antimicrob. Agents Chemother. 58, 4657-4665.
55. Snoek-Van Beurden, P. A. And Von Den Hoff, J. W. (2005). Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors. Biotechniques 38, 73-83.
56. Subbian, S., Tsenova, L., Yang, G., O'Brien, P., Parsons, S., Peixoto, B., Taylor, L., Fallows, D. And Kaplan, G. (2011). Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response. Open Biol. 1, 110016.
57. Tosh, K., Campbell, S. J., Fielding, K., Sillah, J., Bah, B., Gustafson, P., Manneh, K., Lisse, I., Sirugo, G., Bennett, S. et al. (2006). Variants inthe SP110 gene are associated with genetic susceptibility to tuberculosis in West Africa. Proc. Natl. Acad. Sci. USA 103, 10364-10368.
58. Via, L. E., Schimel, D., Weiner, D. M., Dartois, V., Dayao, E., Cai, Y., Yoon, Y.-S., Dreher, M. R., Kastenmayer, R. J., Laymon, C. M. et al. (2012). Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [18F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography. Antimicrob. Agents Chemother. 56, 4391-4402.
59. Via, L. E., Weiner, D. M., Schimel, D., Lin, P. L., Dayao, E., Tankersley, S. L., Cai, Y., Coleman, M. T., Tomko, J., Paripati, P. et al. (2013). Differential virulence and disease progression following Mycobacterium tuberculosis complex infection of the common marmoset (Callithrix jacchus). Infect. Immun. 81, 2909-2919.
60. Volkman, H. E., Pozos, T. C., Zheng, J., Davis, J. M., Rawls, J. F. And Ramakrishnan, L. (2010). Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science 327, 466-469.
61. Volpe, E., Cappelli, G., Grassi, M., Martino, A., Serafino, A., Colizzi, V., Sanarico, N. And Mariani, F. (2006). Gene expression profiling of human macrophages at late time of infection with Mycobacterium tuberculosis. Immunology 118, 449-460.
62. Weinstein, E. A., Liu, L., Ordonez, A. A., Wang, H., Hooker, J. M., Tonge, P. J. And Jain, S. K. (2012). Noninvasive determination of 2-[18F]-fluoroisonicotinic acid hydrazide pharmacokinetics by positron emission tomography in Mycobacterium tuberculosis-infected mice. Antimicrob. Agents Chemother. 56, 6284-6290.
63. Wells, W. F. And Lurie, M. B. (1941). Experimental airborne disease: quantitative natural respiratory contagion of tuberculosis. Am. J. Epidemiol. 34, 21-40.
64. WHO (2011). The Immunological Basis for Immunization Series. Module 5: Tuberculosis. Geneva, Switzerland: World Health Organization.
65. Yamamura, Y. (1958). The pathogenesis of tuberculous cavities. Bibl. Tuberc. 13, 13-37.
66. Yan, B.-S., Pichugin, A. V., Jobe, O., Helming, L., Eruslanov, E. B., Gutierrez-Pabello, J. A., Rojas, M., Shebzukhov, Y. V., Kobzik, L. And Kramnik, I. (2007). Progression of pulmonary tuberculosis and efficiency of bacillus Calmette-Guerin vaccination are genetically controlled via a common sst1-mediated mechanism of innate immunity. J. Immunol. 179, 6919-6932.